← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

VERO logoVenus Concept Inc.(VERO)Earnings, Financials & Key Ratios

VERO•NASDAQ
$0.27
$498989 mkt cap·Price updated Apr 24, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryAesthetics, dermatology, and wound care
AboutVenus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.Show more
  • Revenue$65M-15.1%
  • EBITDA-$23M+3.7%
  • Net Income-$47M-26.2%
  • EPS (Diluted)-66.28-869.0%
  • Gross Margin68.34%
  • EBITDA Margin-35.93%-13.4%
  • Operating Margin-41.93%-13.1%
  • Net Margin-72.49%-48.6%
  • ROE-1655.95%
  • ROIC-39.8%-32.9%
  • Debt/Equity15.16
  • Interest Coverage-3.55+13.5%
Technical→

VERO Key Insights

Venus Concept Inc. (VERO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Share count reduced 87.0% through buybacks
  • ✓Trading at only 0.1x book value

✗Weaknesses

  • ✗High debt to equity ratio of 15.2x
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 2 (bottom 2%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Sales declining 10.1% over 5 years
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

VERO Price & Volume

Venus Concept Inc. (VERO) stock price & volume — 10-year historical chart

Loading chart...

VERO Growth Metrics

Venus Concept Inc. (VERO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-10.1%
3 Years-15.01%
TTM-12.39%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-8.91%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-209.73%

Return on Capital

10 Years-71.94%
5 Years-37.54%
3 Years-41.93%
Last Year-54.16%

VERO Peer Comparison

Venus Concept Inc. (VERO) competitors in Aesthetics, dermatology, and wound care — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
INMD logoINMDInMode Ltd.Direct Competitor861.05M13.599.50-6.16%25.33%14.52%0.02
SSKN logoSSKNSTRATA Skin Sciences, Inc.Direct Competitor5.14M0.14-0.520.61%-35.64%-8.4%3.31
LASE logoLASELaser Photonics CorporationDirect Competitor16.46M0.74-3.37-13.31%-105.37%-183.55%0.49
HIMS logoHIMSHims & Hers Health, Inc.Product Competitor6.94B26.8852.7159%5.47%23.73%2.07
SKIN logoSKINThe Beauty Health CompanyProduct Competitor120.86M0.93-5.83-10.02%-3.16%-15.42%6.20
NVCR logoNVCRNovoCure LimitedProduct Competitor1.88B16.50-13.528.28%-25.66%-50.82%0.85
MDT logoMDTMedtronic plcSupply Chain99.48B77.6021.503.62%13%9.45%0.59
SYK logoSYKStryker CorporationSupply Chain111.96B292.3334.8011.16%12.92%15.04%0.66

Compare VERO vs Peers

Venus Concept Inc. (VERO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs INMD

Most directly comparable listed peer for VERO.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare VERO against a more recognizable public peer.

Peer Set

Compare Top 5

vs INMD, SSKN, LASE, HIMS

VERO Income Statement

Venus Concept Inc. (VERO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue15.6M21.3M21.96M110.41M78.01M105.62M99.5M76.35M64.83M58.88M
Revenue Growth %-9.46%36.52%3.09%402.85%-29.34%35.39%-5.8%-23.26%-15.09%-12.39%
Cost of Goods Sold10.43M12.15M12.45M33.75M26.62M31.53M33.53M24.19M20.53M20.98M
COGS % of Revenue66.87%57.05%56.7%30.57%34.13%29.85%33.7%31.68%31.66%-
Gross Profit
5.17M▲ 0%
9.15M▲ 77.0%
9.51M▲ 3.9%
76.65M▲ 706.4%
51.39M▼ 33.0%
74.09M▲ 44.2%
65.97M▼ 11.0%
52.17M▼ 20.9%
44.31M▼ 15.1%
37.89M▲ 0%
Gross Margin %33.13%42.95%43.3%69.43%65.87%70.15%66.3%68.32%68.34%64.36%
Gross Profit Growth %9.58%76.96%3.92%706.36%-32.96%44.18%-10.96%-20.92%-15.07%-
Operating Expenses24.1M26.43M35.41M106.93M119.29M88.86M100.85M80.48M71.49M72.63M
OpEx % of Revenue154.49%124.1%161.29%96.85%152.91%84.13%101.36%105.4%110.27%-
Selling, General & Admin16.63M19.29M27.04M98.9M84.08M81.99M89.89M72.28M64.8M66.96M
SG&A % of Revenue106.58%90.59%123.15%89.58%107.78%77.63%90.35%94.66%99.95%-
Research & Development7.47M7.13M8.37M8.03M7.75M9.65M10.95M8.2M6.69M5.66M
R&D % of Revenue47.91%33.5%38.14%7.28%9.94%9.13%11.01%10.74%10.32%-
Other Operating Expenses000027.45M-2.77M0000
Operating Income
-18.93M▲ 0%
-17.28M▲ 8.7%
-25.91M▼ 49.9%
-30.28M▼ 16.9%
-67.9M▼ 124.2%
-14.77M▲ 78.3%
-34.88M▼ 136.2%
-28.31M▲ 18.8%
-27.18M▲ 4.0%
-34.74M▲ 0%
Operating Margin %-121.36%-81.15%-117.99%-27.42%-87.03%-13.98%-35.05%-37.08%-41.93%-59%
Operating Income Growth %7.76%8.72%-49.9%-16.88%-124.25%78.25%-136.18%18.83%3.97%-
EBITDA-18.28M-16.71M-24.57M-28.24M-63.09M-9.91M-30.41M-24.19M-23.3M-30.89M
EBITDA Margin %-117.17%-78.45%-111.89%-25.58%-80.88%-9.39%-30.57%-31.69%-35.93%-52.47%
EBITDA Growth %7.05%8.59%-47.03%-14.95%-123.44%84.29%-206.8%20.45%3.72%-27.92%
D&A (Non-Cash Add-back)654K574K1.34M2.04M4.8M4.85M4.46M4.12M3.89M3.84M
EBIT-19.36M-15.76M-26.45M-32.59M-73.29M-17.89M-39.74M-30.23M-39.93M-49.26M
Net Interest Income-2.48M-2.03M-2.22M-7.85M-8.34M-4.96M-4.56M-6.89M-7.66M-5.08M
Interest Income000-297K000000
Interest Expense2.48M2.03M2.22M7.55M8.34M4.96M4.56M6.89M7.66M5.08M
Other Income/Expense-2.91M-504K-2.77M-10.16M-13.74M-8.08M-9.43M-8.81M-20.4M-19.61M
Pretax Income
-21.85M▲ 0%
-17.79M▲ 18.6%
-28.68M▼ 61.2%
-40.44M▼ 41.0%
-81.64M▼ 101.9%
-22.85M▲ 72.0%
-44.31M▼ 93.9%
-37.12M▲ 16.2%
-47.58M▼ 28.2%
-54.35M▲ 0%
Pretax Margin %-140.04%-83.51%-130.62%-36.63%-104.64%-21.63%-44.53%-48.62%-73.39%-92.31%
Income Tax056K47K1.86M1.18M-707K-722K-71K-611K325K
Effective Tax Rate %0%-0.31%-0.16%-4.59%-1.45%3.09%1.63%0.19%1.28%-0.6%
Net Income
-21.85M▲ 0%
-17.84M▲ 18.3%
-28.73M▼ 61.0%
-40.62M▼ 41.4%
-81.71M▼ 101.2%
-23.01M▲ 71.8%
-43.7M▼ 89.9%
-37.25M▲ 14.8%
-47M▼ 26.2%
-54.61M▲ 0%
Net Margin %-140.04%-83.78%-130.83%-36.79%-104.73%-21.79%-43.92%-48.79%-72.49%-92.76%
Net Income Growth %4.9%18.33%-61%-41.4%-101.15%71.83%-89.89%14.76%-26.16%-8.91%
Net Income (Continuing)-21.85M-17.84M-28.73M-42.3M-82.82M-22.14M-43.58M-37.05M-46.97M-54.67M
Discontinued Operations0000000000
Minority Interest004.02M2.5M-471K653K645K570K469K461K
EPS (Diluted)
-213.23▲ 0%
-152.86▲ 28.3%
-192.87▼ 26.2%
-74.49▲ 61.4%
-33.92▲ 54.5%
-6.34▲ 81.3%
-9.91▼ 56.3%
-6.84▲ 31.0%
-66.28▼ 869.0%
-29.38▲ 0%
EPS Growth %4.9%28.31%-26.17%61.38%54.46%81.31%-56.31%30.98%-869.01%-209.73%
EPS (Basic)-213.23-152.86-192.87-74.49-33.92-6.34-9.91-6.84-66.28-
Diluted Shares Outstanding102.45K116.72K148.94K567.8K2.44M3.63M4.4M5.44M709K1.86M
Basic Shares Outstanding102.45K116.72K148.94K567.8K2.44M3.63M4.4M5.44M709K1.86M
Dividend Payout Ratio----------

VERO Balance Sheet

Venus Concept Inc. (VERO) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets17.94M31.73M29.49M99.7M115.4M110.28M83.71M66.44M48.51M45.82M
Cash & Short-Term Investments11.91M23.55M16.12M15.67M34.3M30.88M11.57M5.4M4.27M5.93M
Cash Only11.91M23.55M16.12M15.67M34.3M30.88M11.57M5.4M4.27M5.93M
Short-Term Investments0000000000
Accounts Receivable2.48M3.86M6.57M58.98M56.35M49.65M39.49M30.57M19.33M16.89M
Days Sales Outstanding58.0566.22109.2194.98263.66171.56144.88146.15108.83108.53
Inventory2.74M2.76M5.52M18.84M17.76M26.21M29.79M28.68M17.56M21.77M
Days Inventory Outstanding95.9582.94161.89203.78243.47303.43324.29432.74312.26316.7
Other Current Assets01.56M03.1M2.17M808K1.17M503K495K435K
Total Non-Current Assets1.56M1.24M1.48M91.42M45.12M47.1M41.67M27.21M19.67M15.8M
Property, Plant & Equipment1.46M1.14M1.3M4.65M3.54M2.67M7.72M5.84M4.22M3.33M
Fixed Asset Turnover10.69x18.71x16.90x23.75x22.04x39.57x12.89x13.08x15.37x15.59x
Goodwill002.6M27.45M000000
Intangible Assets00022.34M18.86M15.39M11.92M8.45M4.97M2.38M
Long-Term Investments100K100K38.2M35.66M21.15M27.71M20.04M11.32M8.53M27.33M
Other Non-Current Assets00-40.92M710K685K1.04M1.04M574K488K10.21M
Total Assets
19.5M▲ 0%
32.97M▲ 69.1%
30.97M▼ 6.1%
191.13M▲ 517.1%
160.53M▼ 16.0%
157.37M▼ 2.0%
125.38M▼ 20.3%
93.65M▼ 25.3%
68.18M▼ 27.2%
61.62M▲ 0%
Asset Turnover0.80x0.65x0.71x0.58x0.49x0.67x0.79x0.82x0.95x0.92x
Asset Growth %-26.36%69.09%-6.06%517.08%-16.01%-1.96%-20.33%-25.3%-27.2%-88.24%
Total Current Liabilities13.05M14.05M9.38M48.17M32.52M34.72M39.59M31.16M30.29M50.65M
Accounts Payable1.74M2.04M3.81M9.4M6.32M8.42M8.03M9.04M6.48M7.11M
Days Payables Outstanding60.8961.4111.85101.6686.6797.4687.46136.39115.3116.59
Short-Term Debt7.45M7.73M49K7.79M0543K9.54M5.75M8.27M26.32M
Deferred Revenue (Current)1.52M1.52M1.41M6.44M3.7M4.71M4.16M2.54M1.86M7.58M
Other Current Liabilities01.13M1.77M3.14M7.53M18.99M15.5M11.21M6.57M9.94M
Current Ratio1.37x2.26x3.14x2.07x3.55x3.18x2.11x2.13x1.60x1.60x
Quick Ratio1.16x2.06x2.56x1.68x3.00x2.42x1.36x1.21x1.02x1.02x
Cash Conversion Cycle93.1187.76159.25297.09420.46377.54381.72442.5305.79308.63
Total Non-Current Liabilities149.99M5.73M20.01M66.28M84.25M81.06M77.05M75.94M35.06M7.84M
Long-Term Debt13M5.27M19.42M61.23M79.6M77.33M70M70.79M31.44M5M
Capital Lease Obligations0000004.22M3.16M2M6.69M
Deferred Tax Liabilities001.89M1.02M811K46K015K00
Other Non-Current Liabilities136.99M459K594K2.35M2.06M2.33M1.86M1.31M1.26M5.18M
Total Liabilities163.04M19.78M29.39M114.45M116.76M115.78M116.64M107.1M65.35M58.49M
Total Debt20.45M13M19.47M69.02M79.6M77.87M83.77M79.7M43.03M32.67M
Net Debt8.54M-10.54M3.35M53.35M45.3M46.99M72.2M74.3M38.76M26.73M
Debt / Equity-0.99x3.47x0.90x1.82x1.87x9.59x-15.16x15.16x
Debt / EBITDA----------1.06x
Net Debt / EBITDA----------0.87x
Interest Coverage-7.62x-8.53x-11.65x-4.01x-8.14x-2.98x-7.65x-4.11x-3.55x-9.69x
Total Equity
-143.54M▲ 0%
13.19M▲ 109.2%
5.6M▼ 57.5%
76.68M▲ 1268.3%
43.76M▼ 42.9%
41.6M▼ 4.9%
8.74M▼ 79.0%
-13.45M▼ 253.9%
2.84M▲ 121.1%
3.13M▲ 0%
Equity Growth %-17.46%109.19%-57.53%1268.27%-42.93%-4.95%-78.99%-253.91%121.1%126.56%
Book Value per Share-1401.10113.0437.63135.0417.9211.461.99-2.474.001.69
Total Shareholders' Equity-143.54M13.19M1.58M74.18M44.23M40.94M8.09M-14.02M2.37M2.67M
Common Stock2K3K4K24K26K27K29K30K30K31K
Retained Earnings-146.65M-164.49M-193.21M-75.69M-157.39M-180.41M-224.1M-261.9M-308.9M-355.55M
Treasury Stock0000000000
Accumulated OCI14K-79K-50K0000000
Minority Interest004.02M2.5M-471K653K645K570K469K461K

VERO Cash Flow Statement

Venus Concept Inc. (VERO) cash flow — operating, investing & free cash flow history

Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-16.16M-19.26M-28.7M-39.59M-28.65M-19.77M-26.98M-12.86M-11.07M-11.07M
Operating CF Margin %-103.62%-90.42%-130.71%-35.86%-36.72%-18.72%-27.12%-16.84%-17.07%-
Operating CF Growth %32.98%-19.13%-49.04%-37.97%27.64%30.99%-36.46%52.34%13.94%-880.5%
Net Income-21.85M-17.84M-28.73M-42.3M-82.82M-22.14M-43.58M-37.05M-46.97M-54.61M
Depreciation & Amortization654K574K813K2.04M4.8M4.85M4.46M4.12M3.89M3.85M
Stock-Based Compensation466K465K667K2.16M2.14M2.07M2.1M1.57M1.04M570K
Deferred Taxes392K-1.43M1.95M-1.13M-438K-165K-709K-69K-443K873K
Other Non-Cash Items737K578K470K12.47M55.38M764K10.33M6.94M19.34M24.3M
Working Capital Changes3.43M-1.6M-3.87M-12.84M-7.72M-5.15M417K11.64M12.08M4.65M
Change in Receivables-987K-1.38M-4.48M-21.09M93K-869K9.86M14.89M12.49M1.56M
Change in Inventory2.89M-19K-2.76M6.43M-1.02M-4.26M-5.78M-324K4.46M1.85M
Change in Payables709K246K1.8M-5.97M-2.98M2.1M-385K1M-2.21M80K
Cash from Investing-1.17M1.62M-1.01M6.38M-2.39M-552K-336K-116K-123K-294K
Capital Expenditures-1.17M-229K-1.01M-1.12M-291K-512K-336K-116K-123K-294K
CapEx % of Revenue7.52%1.08%4.58%1.02%0.37%0.48%0.34%0.15%0.19%-
Acquisitions2K0-7.5M0-2.1M-40K0000
Investments----------
Other Investing2K1.85M07.51M000000
Cash from Financing12.11M29.37M22.24M42.2M49.67M16.82M8.01M6.8M10.06M22.19M
Debt Issued (Net)0-3M6.28M16.42M1.42M-738K-543K09.2M18.91M
Equity Issued (Net)1000K1000K1000K01000K1000K1000K1000K987K1M
Dividends Paid0000000000
Share Repurchases0000000000
Other Financing41K43K392K25.78M-911K817K-101K-275K-126K0
Net Change in Cash
-5.22M▲ 0%
11.64M▲ 322.9%
-7.44M▼ 163.9%
8.99M▲ 220.8%
18.63M▲ 107.2%
-3.5M▼ 118.8%
-19.31M▼ 451.0%
-6.17M▲ 68.0%
-1.13M▲ 81.8%
1.44M▲ 0%
Free Cash Flow
-17.34M▲ 0%
-19.48M▼ 12.4%
-29.7M▼ 52.5%
-40.72M▼ 37.1%
-28.94M▲ 28.9%
-20.28M▲ 29.9%
-27.32M▼ 34.7%
-12.97M▲ 52.5%
-11.19M▲ 13.8%
-20.75M▲ 0%
FCF Margin %-111.13%-91.49%-135.29%-36.88%-37.1%-19.2%-27.45%-16.99%-17.26%-35.24%
FCF Growth %29.45%-12.39%-52.45%-37.07%28.92%29.92%-34.67%52.5%13.76%-156.07%
FCF per Share-169.22-166.94-199.44-71.71-11.85-5.59-6.21-2.38-15.78-15.78
FCF Conversion (FCF/Net Income)0.74x1.08x1.00x0.97x0.35x0.86x0.62x0.35x0.24x0.38x
Interest Paid1.74M1.5M1.76M6.17M1.47M3.29M4.15M4.47M1.61M-23K
Taxes Paid56K28K35K1.09M941K116K329K124K128K31K

VERO Key Ratios

Venus Concept Inc. (VERO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201620172018201920202021202220232024TTM
Return on Equity (ROE)--135.23%-305.63%-98.73%-135.68%-53.92%-173.64%--1655.95%-1742.63%
Return on Invested Capital (ROIC)--489.11%-335.02%-32.68%-46.49%-12.47%-30.86%-29.95%-39.8%-39.8%
Gross Margin33.13%42.95%43.3%69.43%65.87%70.15%66.3%68.32%68.34%64.36%
Net Margin-140.04%-83.78%-130.83%-36.79%-104.73%-21.79%-43.92%-48.79%-72.49%-92.76%
Debt / Equity-0.99x3.47x0.90x1.82x1.87x9.59x-15.16x15.16x
Interest Coverage-7.62x-8.53x-11.65x-4.01x-8.14x-2.98x-7.65x-4.11x-3.55x-9.69x
FCF Conversion0.74x1.08x1.00x0.97x0.35x0.86x0.62x0.35x0.24x0.38x
Revenue Growth-9.46%36.52%3.09%402.85%-29.34%35.39%-5.8%-23.26%-15.09%-12.39%

VERO Frequently Asked Questions

Venus Concept Inc. (VERO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Venus Concept Inc. (VERO) reported $58.9M in revenue for fiscal year 2024. This represents a 242% increase from $17.2M in 2015.

Venus Concept Inc. (VERO) saw revenue decline by 15.1% over the past year.

Venus Concept Inc. (VERO) reported a net loss of $54.6M for fiscal year 2024.

Dividend & Returns

Venus Concept Inc. (VERO) has a return on equity (ROE) of -1656.0%. Negative ROE indicates the company is unprofitable.

Venus Concept Inc. (VERO) had negative free cash flow of $20.7M in fiscal year 2024, likely due to heavy capital investments.

Explore More VERO

Venus Concept Inc. (VERO) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.